$208.33
|
Cindy Hoots
| 12/31/2023 | SVP Chief Digital Officer and CIO | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 01/15/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 01/31/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 02/15/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 02/28/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 03/15/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 03/31/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 04/15/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 04/30/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 05/15/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 05/31/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 06/15/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 06/30/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 07/15/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 07/31/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 08/15/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 08/31/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 09/15/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 09/30/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 10/15/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 10/31/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 11/15/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 11/30/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 12/15/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |
$208.33
|
David Fredrickson
| 12/31/2023 | Evp Oncology Business | Astrazeneca Pharmaceuticals LP | INDIVIDUAL |